Nano Lett. 2011 Oct 12;11(10):4411-4. Epub 2011 Sep 14.

Nanoparticles targeting the infarcted heart.

Dvir T, Bauer M, Schroeder A, Tsui JH, Anderson DG, Langer R, Liao R, Kohane DS.

Source

Department of Chemical Engineering, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.

Abstract

We report a nanoparticulate system capable of targeting the heart after myocardial infarction (MI). Targeting is based on overexpression of angiotensin II type 1 (AT1) receptor in the infarcted heart. Liposomes 142 nm in diameter were conjugated with a ligand specific to AT1. The nanoparticles were able to specifically target cardiac cells in vitro, and in the infarcted heart after intravenous injection in vivo. This system may be useful for delivering therapeutic agents specifically to the infarcted heart.

PMID:: 21899318; [PubMed - indexed for MEDLINE]
PMCID:: PMC3192253; [Available on 2012/10/12]

LinkOut - more resources

Full Text Sources

Medical

Heart Attack - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Modeling oxygenation and selective delivery of drug carriers post-myocardial infarction. [Adv Exp Med Biol. 2008]
Modeling oxygenation and selective delivery of drug carriers post-myocardial infarction.
Wang B, Scott RC, Pattillo CB, Prabhakarpandian B, Sundaram S, Kiani MF. Adv Exp Med Biol. 2008; 614:333-43.
Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction. [Biotechnol Bioeng. 2007]
Targeted delivery of antibody conjugated liposomal drug carriers to rat myocardial infarction.
Scott RC, Wang B, Nallamothu R, Pattillo CB, Perez-Liz G, Issekutz A, Del Valle L, Wood GC, Kiani MF. Biotechnol Bioeng. 2007 Mar 1; 96(4):795-802.
Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. [Heart. 2005]
Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, Oda S, Takeuchi K, Kim S, Iwao H, Yoshikawa J. Heart. 2005 Aug; 91(8):1080-5.
Review Passive and active drug targeting: drug delivery to tumors as an example. [Handb Exp Pharmacol. 2010]
Review Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP. Handb Exp Pharmacol. 2010; (197):3-53.
Review Review: nanoparticles in delivery of cardiovascular drugs. [Pak J Pharm Sci. 2007]
Review Review: nanoparticles in delivery of cardiovascular drugs.
Arayne MS, Sultana N, Qureshi F. Pak J Pharm Sci. 2007 Oct; 20(4):340-8.

See reviews... See all...

Cited by 1 PubMed Central article

Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies. [Cardiol Res Pract. 2012]
Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies.
Giraud MN, Guex AG, Tevaearai HT. Cardiol Res Pract. 2012; 2012:971614. Epub 2012 Apr 22.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Nanoparticles targeting the infarcted heart.
Nanoparticles targeting the infarcted heart.
Nano Lett. 2011 Oct 12 ;11(10):4411-4. Epub 2011 Sep 14 .

PubMed
Ocular anomalies in fragile X syndrome.
Ocular anomalies in fragile X syndrome.
J Am Optom Assoc. 1990 Apr ;61(4):316-23.

PubMed
Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and assoc...
Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias.
J Am Acad Dermatol. 1990 May ;22(5 Pt 1):705-17.

PubMed
Correlation between thyrotropin-displacing activity and human thyroid-stimulatin...
Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders.
J Clin Endocrinol Metab. 1979 Mar ;48(3):398-402.

PubMed
Individual insurance and access to care.
Individual insurance and access to care.
Inquiry. 2011 Summer ;48(2):155-68.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Nanoparticles targeting the infarcted heart.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information